Education

Dr. Faizi A. Jamal, Chief, Division of Cardiology and Director, Non-Invasive Cardiology Laboratory at the City of Hope National Medical Center has been at the…

AL Amyloidosis: A Real-World Experience with CAR-T Cell TherapyMelinda SY Tan1 , Rahma Warsame1 , Ricardo Parrondo2 , Eli Muchtar1 , Taxiarchis Kourelis1 , Francis…

Key PointsElranatamab elicits deep and rapid heme responses in patients with relapsed AL amyloidosis, including minimal residual disease negativity.No new adverse…

Amyloid light-chain (AL) amyloidosis is the most prevalent type of diagnosed systemic amyloidosis in Western countries, characterized by the deposition of misfolded…

Our patient speakers at the Amyloidosis Speakers Bureau are powerful educators and offer compelling insights. Have a listen to this brief clip from Robert where he…

If you’ve been diagnosed with the rare diseases of multiple myeloma or amyloidosis, it’s important to be evaluated by hematology experts before beginning treatment…

AbstractWe report the case of an 82-year-old male with a history of bronchiectasis, asthma, and atrial fibrillation, who presented with progressive exertional…

AbstractINTRODUCTIONWe investigated whether older adults with subjective memory complaints (SMC) and amyloid‐β accumulation may show clinical progression over 2…

AbstractAims: The role of sodium-glucose co-transporter 2 inhibitors (SGLT2i) in patients with cardiac amyloidosis (CA) is controversial. However, they have shown…

AbstractBackground: Amyloidosis is the extracellular accumulation of amyloid proteins in diverse organs. While ocular and periocular involvement is rare, it can be…